Skip to main content
Clinical Trials/NCT07764770
NCT07764770CompletedNot Applicable

Structured Telemonitoring as an Adjunct to Conservative Management of Temporomandibular Disorder-Related Orofacial Pain: A Randomized Clinical Trial

University Magna Graecia1 site in 1 country60 target enrollmentStarted: January 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Maximum pain-free mouth opening (mm)

Study Overview

Brief Summary

This prospective randomized clinical trial evaluates the effectiveness of a structured telemonitoring protocol as an adjunct to conservative management in patients with temporomandibular disorder (TMD)-related orofacial pain. Participants receive standardized conservative therapy based on behavioural counselling, habit reversal training, and home-based self-management exercises, with or without structured telemonitoring. Clinical outcomes include pain intensity, mandibular function, and oral behaviours, assessed over a 9-month follow-up period. The study aims to determine whether telemonitoring improves treatment adherence, behavioural modification, and clinical outcomes compared with conventional in-office follow-up.

Detailed Description

This prospective randomized clinical trial evaluates the effectiveness of a structured telemonitoring protocol as an adjunct to conservative management in patients with temporomandibular disorder (TMD)-related orofacial pain. Participants receive standardized conservative therapy based on behavioural counselling, habit reversal training, and home-based self-management exercises, with or without structured telemonitoring. Clinical outcomes include pain intensity, mandibular function, and oral behaviours, assessed over a 9-month follow-up period. The study aims to determine whether telemonitoring improves treatment adherence, behavioural modification, and clinical outcomes compared with conventional in-office follow-up.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults aged 18-80 years.
  • •Diagnosis of temporomandibular disorder (TMD) according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD).
  • •Presence of chronic orofacial pain persisting for more than 30 days.
  • •Diagnosis of myofascial pain involving the masticatory muscles, with or without headache attributed to TMD.
  • •Ability to use a mobile device compatible with telemonitoring procedures.

Exclusion Criteria

  • •Systemic diseases affecting pain perception or neuromuscular function (including autoimmune, neurological, or neoplastic disorders).
  • •History of severe orofacial trauma.
  • •Previous major temporomandibular joint surgery.
  • •Ongoing orthodontic treatment.
  • •Current use of occlusal splints.
  • •Current use of muscle relaxants or psychoactive medications.

Arms & Interventions

Telemonitoring group (TG)

Experimental

The TG received an active management protocol consisting of standard myofascial therapy combined with monthly in-office clinical evaluations and weekly structured remote interactions.

Intervention: Structured Telemonitoring (Behavioral)

Control group (CG)

Active Comparator

CG received conventional care based on monthly in-office clinical follow-up and standard therapeutic instructions without any form of remote monitoring.

Intervention: Conservative Management (Behavioral)

Outcomes

Primary Outcomes

Maximum pain-free mouth opening (mm)

Time Frame: Baseline (T0), 3 months (T1), and 9 months (T2)

Change in maximum pain-free mouth opening measured in millimetres (mm) as an indicator of mandibular functional improvement.

Mandibular lateral excursions (mm)

Time Frame: Baseline (T0), 3 months (T1), and 9 months (T2)

Change in right and left mandibular lateral excursion measured in millimetres (mm).

Protrusive movement (mm)

Time Frame: Baseline (T0), 3 months (T1), and 9 months (T2)

Change in maximum mandibular protrusive movement measured in millimetres (mm).

Pain intensity assessed using the Visual Analogue Scale (VAS)

Time Frame: Baseline (T0), 3 months (T1), and 9 months (T2)

Change in perceived pain intensity assessed using a 10-cm Visual Analogue Scale (VAS), where higher scores indicate greater pain intensity. Scale range is 0 to 10.

Secondary Outcomes

  • Oral Behaviours Checklist (OBC) score(Baseline (T0), 3 months (T1), and 9 months (T2))

Investigators

Sponsor
University Magna Graecia
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Amerigo Giudice

Professor

University Magna Graecia

Study Sites (1)

Loading locations...

Similar Trials

Telemonitoring for TMD-Related Pain | Clinical Trial